FIELD: chemistry.
SUBSTANCE: invention relates to novel 5-fluorouracil derivatives of general formula (I) or pharmaceutically acceptable salts thereof. In general formula (I), R1 denotes a hydrogen atom or a protective hydroxy group which is selected from a C1-C6aliphatic acyl group; C5-C6 alicyclic acyl group; aromatic acyl group which is selected from a benzoyl group or a halogen-benzoyl group, R2 denotes a lower alkoxy-lower alkyl group; X denotes CH or a nitrogen atom and Y denotes a halogen atom.
EFFECT: compounds have anti-tumour activity, balanced with toxicity level, and can be used as an active ingredient for producing a drug for treating malignant diseases.
11 cl, 4 dwg, 4 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOUR AGENT INTENSIFIER | 2010 |
|
RU2548913C2 |
NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION | 2007 |
|
RU2437880C2 |
DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES | 2007 |
|
RU2437885C2 |
INDANE CONDENSED DERIVATIVES, METHOD OF THEIR SYNTHESIS AND COMPOSITION SHOWING ANTITUMOR EFFECT | 1995 |
|
RU2124017C1 |
3-PHENYLCINNOLIN ANALOGUE AND BASED ON IT ANTI-TUMOR AGENT | 2003 |
|
RU2324683C2 |
DERIVATIVES OF 2,4-OXAZOLIDINEDIONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS, MEDICINAL COMPOSITION SHOWING HYPOGLYCAEMIC AND HYPOLIPIDEMIC EFFECT, METHOD OF BLOOD GLUCOSE AND LIPID CONTENT DECREASE IN MAMMALIAN WITH DIABETES MELLITUS OR HYPERLIPIDEMIA | 1994 |
|
RU2126797C1 |
NEW AMINOPYRIMIDINE DERIVATIVES AS PLK1 INHIBITORS | 2007 |
|
RU2458062C2 |
DERIVATIVES OF CAMPTOTHECIN, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2138503C1 |
THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
SUBSTITUTED DERIVATIVES OF NUCLEOSIDE, A METHOD OF THEIR SYNTHESIS (VARIANTS), A DRUG, A METHOD OF TREATMENT AND PROPHYLAXIS | 1995 |
|
RU2130029C1 |
Authors
Dates
2014-01-10—Published
2010-10-26—Filed